Supernus Pharmaceuticals to acquire this Pharmaceuticals company for $400 million
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) recently announced that it had entered a definitive contract to acquire Adamas...
Pro on Southwest fiasco: ‘they blamed everything except their management skills’
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each...
Cryptocurrency and credit card fraud: Q&A with n.exchange
n.exchange is a cryptocurrency exchange specializing in fiat on- and off-ramp to make crypto investment user-friendly....
Should you invest in HT after Huobi Wallet launched Cloud Wallet?
Huobi Token HT/USD is the native cryptocurrency token of the Huobi Global exchange. HT is a...
Protagonist Therapeutics shares nearly doubled on Monday: explore why
Shares of Protagonist Therapeutics Inc (NASDAQ: PTGX) nearly doubled on Monday as the U.S. FDA said...
Is now the right time to buy SuperRare after the Binance listing?
SuperRare RARE/USD is an NFT marketplace designed to collect and trade unique, limited-edition digital artworks. The...
Apple might not have to change its App Store policy for years
A month after a U.S. court barred Apple Inc (NASDAQ: AAPL) from restricting developers to its...
Is it too late to buy Renren stock on Monday?
Renren Inc. (NYSE: RENN) stock closed soared higher on Friday and hit a new 52-week high...
Here is why Merck wants FDA Approval for molnupiravir
Merck & Co. Inc. (NYSE: MRK) announced that it had sought the Food and Drug Administration’s...
Behind BTC’s Growing Dominance | Invezz
Into the Block covers Bitcoin’s (BTC/USD) growing dominance as it records positive on-chain data, reaching new...